TrialPloS one2022

Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial.

Alexandra Audemard-Verger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.